Entering text into the input field will update the search result below

Sarepta Therapeutics, Inc. (SRPT) CEO Doug Ingram on Q4 2020 Results - Earnings Call Transcript

Mar. 02, 2021 1:07 AM ETSarepta Therapeutics, Inc. (SRPT)
SA Transcripts profile picture
SA Transcripts

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q4 2020 Earnings Conference Call March 1, 2021 4:30 AM ET

Corporate Participants

Mary Jenkins - Senior Manager, Investor Relations

2Doug Ingram - President and Chief Executive Officer

Ian Estepan - SVP, Chief of Staff and Corporate Affairs

Gilmore O’Neill - EVP, R&D and Chief Medical Officer

Louise Rodino-Klapac - Executive Vice President, Chief Scientific Office

Conference Call Participants

Alethia Young - Cantor Fitzgerald

Brian Abrahams - RBC Capital Markets

Salveen Richter - Goldman Sachs

Ritu Baral - Cowen

Difei Yang - Mizuho Securities

Debjit Chattopadhyay - Guggenheim

Gena Wang - Barclays

Gil Blum - Needham & Company

Tazeen Ahmad - Bank of America

Vincent Chen - Bernstein

Tara Bancroft - Piper Sandler

Brian Skorney - Baird

Marty Auster - Credit Suisse

Shawn Egan - Citi

Kelly Girskis - SVB Leerink

Jackie Yan - Oppenheimer


Good afternoon, ladies and gentlemen, and welcome to the Sarepta Therapeutics Fourth Quarter and Full Year 2020 Earnings Conference Call. At this time all participants' lines are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] As a reminder, today's program is being recorded.

At this time, I'll turn the call over to Mary Jenkins, Senior Manager, Investor Relations. Please go ahead.

Mary Jenkins

Thank you, operator, and thank you all for joining today's call. Earlier today, we released our financial results for the fourth quarter and full year 2020. The press release is available on our Web site at sarepta.com and our 10-K was filed with the Securities & Exchange Commission earlier this afternoon.

Joining us on the call today are Doug Ingram, Ian Estepan, Dallan Murray, Dr. Gilmore O’Neill, and Dr. Louise Rodino-Klapac. After our formal remarks, we'll open up the call for Q&A.

I'd like to note that during this

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About SRPT

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on SRPT

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.